Back to search

What will be the role of I-123 MIBG in improving the outcome of medically treated heart failure patients?

Data up to Jan 2025

Published2012
Citations4
References66
Clinical Trials (1)

Total Citations Per Year

Abstract

References (66)

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

2016 • 11,500 citations

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

1991 • 8,296 citations

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction

1992 • 5,885 citations

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1999 • 5,053 citations

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)

1999 • 4,963 citations

Effects of Enalapril on Mortality in Severe Congestive Heart Failure

1987 • 4,763 citations

The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure

1996 • 4,580 citations

Heart Disease and Stroke Statistics—2009 Update

2009 • 3,914 citations

Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)

1988 • 3,818 citations

Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions

1992 • 3,708 citations

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure

1984 • 3,130 citations

Heart Disease and Stroke Statistics—2009 Update

2008 • 3,119 citations

Effect of Carvedilol on Survival in Severe Chronic Heart Failure

2001 • 3,011 citations

A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure

1991 • 2,867 citations

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

2005 • 2,255 citations

Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations

2015 • 1,908 citations

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure

1993 • 1,775 citations

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

2001 • 1,774 citations

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials

1995 • 1,526 citations

Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure

1995 • 1,301 citations

Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure

2002 • 1,287 citations

A double‐blind, placebo‐controlled trial

1986 • 1,281 citations

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.

1993 • 1,240 citations

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy

1993 • 1,218 citations

Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure

1999 • 1,194 citations

Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure

1998 • 1,142 citations

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.

1994 • 1,051 citations

Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

1993 • 877 citations

Digoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker?

2016 • 872 citations

Myocardial Iodine-123 Meta-Iodobenzylguanidine Imaging and Cardiac Events in Heart Failure

2010 • 814 citations

Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.

1989 • 447 citations

Captopril in heart failure. A double blind controlled trial.

1984 • 385 citations

Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.

1984 • 267 citations

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.

1989 • 246 citations

Abnormal Awake Respiratory Patterns Are Common in Chronic Heart Failure and May Prevent Evaluation of Autonomic Tone by Measures of Heart Rate Variability

1997 • 214 citations

I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study

2007 • 210 citations

Cardiac Sympathetic Imaging With mIBG in Heart Failure

2010 • 188 citations

Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison

1998 • 185 citations

Effect of spironolactone on cardiacsympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy

2003 • 148 citations

Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure

2003 • 146 citations

Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure

2004 • 144 citations

Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to β-blocker therapy in patients with dilated cardiomyopathy

1997 • 130 citations

Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction

2005 • 119 citations

Mechanisms of Disease: β-adrenergic receptors—alterations in signal transduction and pharmacogenomics in heart failure

2005 • 116 citations

Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.

1985 • 114 citations

ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure.

1997 • 113 citations

Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.

2000 • 107 citations

Effect of Spironolactone on Cardiac Sympathetic Nerve Activity and Left Ventricular Remodeling in Patients with Dilated Cardiomyopathy

2003 • 105 citations

Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: implications for clinical studies

2004 • 104 citations

Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics.

2000 • 104 citations

Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine

2002 • 91 citations

Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol

2007 • 88 citations

Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure

2000 • 85 citations

Limitations of the use of spectral analysis of heart rate variability for the estimation of cardiac sympathetic activity in heart failure

2001 • 82 citations

Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison The NETWORK investigators

1998 • 79 citations

Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study

2000 • 76 citations

Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of ?-blocker therapy in patients with dilated cardiomyopathy

1997 • 60 citations

Prognostic Value of Iodine-123-Metaiodobenzylguanidine Myocardial Uptake and Heart Rate Variability in Chronic Congestive Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy

2005 • 56 citations

Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure.

2005 • 53 citations

Captopril in heart failure.

1988 • 50 citations

Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program

2008 • 46 citations

Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy

2007 • 44 citations

Will Imaging Assist in the Selection of Patients With Heart Failure for an ICD?

2010 • 24 citations

Long-term effects of clinical outcome with low and high dose in the Captopril in Heart Insufficient Patients Study (CHIPS)

2000 • 20 citations

ACE inhibitor dosage at the time of listing predicts survival

2000 • 16 citations

The early anti-oxidant effect of carvedilol predicts the clinical course in congestive heart failure patients

2007 • 13 citations

Cited By (0)

Loading...
What will be the role of I-123 MIBG in improving the outcome of medically treated heart… (2012) – Journal of Nuclear Cardiology | Metascience Observatory Explorer